Human anti-tetanus monoclonal antibodies neutralising infection by c. tetani, method for obtaining said monoclonal antibodies and use thereof in immunotherapy in the case of accidents with possible infection by tetanus bacillus
BR102017005783A2
process for obtaining esculptin and fragments thereof, recombinant sculptin and its uses
BR102016023153A2
COMPOSITION, USE, AND, METHOD FOR TREATING NEURODEGENERATIVE DISEASES
BR102016020617A2
PROCESS, DEVICE AND KIT FOR IN VITRO IMMUNOCROMATOGRAPHIC DIAGNOSIS OF LEPTOSPIROSIS AND / OR FOR DETECTION OF LEPTOSPIRA SPP INFECTION; PROCESS FOR YOUR PREPARATION
BR102016017666A2
COMPOSITION AND USE OF A PEPTIDE
BR102016016410A2
Method and kit for visceral leishmaniasis diagnosis using antigene leishmania infantum proteins
US2017065701A1
Process for preparing an attenuated tetravalent dengue vaccine
BR102015010519A2
serological diagnosis kit for leishmaniasis, based on immunoproteomics and use
US2016311869A1
Polynucleotide, polypeptide with immunosuppressive activity, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with immunosuppressive activity and for preventing or treating conditions that require immunosuppression, and use of a polypeptide
BR102013031043A2
Use of chemical compounds able to inhibit the toxic action of spxomyelinases d from loxoscel spiden poison and pharmaceutical composition understanding the compound compounds
BRPI0502080A
Procedure for obtaining anti-latetic equine serum
BRPI0303416B1
Procedures for obtaining bordetella pertussis lipopolissacaride and obtaining and preparing bordetella pertussis monophosphorylate, using bordetella pertussis monophosphorile lipide
